Allergan clears first FDA hurdle for eyelash enhancer

Eva S on 10 Dec 2008 at 11:18am

After all the cat-fighting between Athena Cosmetics, Athena Bioscience, DermaQuest, Jan Marini and Allergan (maker of Botox Cosmetic) over their eyelash enhancing formulas, Allergan must be having a nice little chuckle to themselves as an FDA advisory panel—the Dermatologic and Ophthalmic Drugs Advisory Committee—gave their support to Allergan's Latisse on Friday.

Latisse is the working name for the eyelash growth stimulator that Allergan hopes to have on the market in 2009. Latisse is based on bimatoprost, which is a synthetic prostaglandin analogue currently used to treat glaucoma.

If approved by the FDA, Latisse will be the first, and according to (12/8/08) only, FDA-approved pharmaceutical on the market for eyelash enhancement. Stay tuned...


Comments (3)

eyelash conditioner
Thank you for sharing this valuable informative article. I am sure that it will help me a lot to know a lot. Waiting to know more from you.
Well I'm not laughing! The FDA was right about their concern. This product darkened my eyes, caused eye pressure and itching. I hate this product and wish it was never allowed in the market. I wish the FDA would have pursued the issue further. It is a disgrace!
Lumigan eyedrops used on eyebrows, lashes (not in eyes!) as well as castor oil work wonders. Much much cheaper and proven results.